Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.
Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders.
Shenandoah Therapeutics is a biotechnology company.
Memento Medicines is a biotech developing bispecific antibody therapies for eye diseases.
Mereo is a new UK-based speciality biopharmaceutical company.
Notch develops immune cell therapy developing a next-generation pipeline that is compatible and focuses on initial cancer cells.
A2 Biotherapeutics develops T cell therapies targeting solid tumors precisely.
Abivax develops medicines that alter the body's natural immune system mechanisms.
CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.
Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies.
Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.
Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.
Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.
Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.
Candid Therapeutics develops therapies for autoimmune diseases using antibody-based technologies that modulate immune system activity.
Fluent Biosciences, a life science company, offering a molecular analysis of cells without the use of complex microfluidic instrumentation.
Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.
Abcuro develops immunotherapies to treat autoimmunity and cancer.
Samsara BioCapital has invested in 132 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Samsara BioCapital's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Biopharma. The firm invests across 20 different industry categories.
Among tracked funding rounds, Candid Therapeutics received $505.0M in a Undisclosed round. Samsara BioCapital's total known invested capital is $12.8B.
Samsara BioCapital's average investment size is $105.2M across its portfolio of 132 companies.
Recent Samsara BioCapital portfolio additions include Inventiva Pharma, Nura Bio, Shenandoah Therapeutics, Memento Medicines, Mereo Biopharma. These companies were founded in 2020 or later.